ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,538Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 623

$1.06M Total Retail Price of All Prescriptions

Rank: 3 out of 623

503 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 503 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 503 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 15,627 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
FUROSEMIDE 780 712 1 5
LISINOPRIL 738 625 2 1
OMEPRAZOLE 734 625 3 7
LEVOTHYROXINE SODIUM 728 623 4 4
WARFARIN SODIUM 605 551 5 14
SIMVASTATIN 579 519 6 2
AMLODIPINE BESYLATE 429 365 7 3
METOPROLOL TARTRATE 375 310 8 9
SERTRALINE HCL 317 241 9 20
OXYCODONE-ACETAMINOPHEN 281 220 S2 10 42
PANTOPRAZOLE SODIUM 280 260 11 26
TRAMADOL HCL 254 221 12 15
ZOLPIDEM TARTRATE 253 189 13 22
ATORVASTATIN CALCIUM 244 219 14 10
POLYETHYLENE GLYCOL 3350 224 210 15 53
HYDROCODONE-ACETAMINOPHEN 221 177 S3 16 17
GABAPENTIN 199 122 17 18
MELOXICAM 198 167 18 50
METOPROLOL SUCCINATE 192 182 19 13
CITALOPRAM HBR 189 163 20 21
LANTUS 185 171 21 41
TRAZODONE HCL 184 154 22 36
VENLAFAXINE HCL ER 177 171 23 96
DONEPEZIL HCL 177 175 23 27
METFORMIN HCL 175 125 25 6
OXYCODONE HCL 169 105 S2 26 30
MIRTAZAPINE 159 156 27 31
CARVEDILOL 155 135 28 32
RANITIDINE HCL 148 119 29 23
ESCITALOPRAM OXALATE 145 134 30 60
BUSPIRONE HCL 142 136 31 94
JANTOVEN 130 130 32 54
NAMENDA 123 123 33 47
POTASSIUM CHLORIDE 120 100 34 24
CLOPIDOGREL 120 113 34 34
PREDNISONE 118 94 36 40
HYDROCHLOROTHIAZIDE 115 97 37 8
ADVAIR DISKUS 115 83 37 39
OXYCODONE HCL-ACETAMINOPHEN 110 32 S2 39 113
IPRATROPIUM-ALBUTEROL 109 107 40 91
AZITHROMYCIN 107 94 41 45
QUETIAPINE FUMARATE 103 102 42 51
FENTANYL 100 93 S2 43 76
CYMBALTA 99 77 44 52
PRAVASTATIN SODIUM 97 69 45 11
LYRICA 94 78 46 86
ATENOLOL 93 86 47 12
NOVOLOG 91 77 48 75
SULFAMETHOXAZOLE-TRIMETHOPRIM 90 67 49 78
CLONIDINE HCL 87 73 50 55
KETOCONAZOLE 86 69 51 182
KLOR-CON M20 86 86 51 62
PLAVIX 85 78 53 46
DIGOXIN 83 82 54 63
SPIRIVA 82 70 55 58
DIVALPROEX SODIUM 81 81 56 77
JANUVIA 79 76 57 87
GLIPIZIDE 79 72 57 33
TAMSULOSIN HCL 79 56 57 35
CEPHALEXIN 79 68 57 102
LEVOFLOXACIN 78 71 61 72
ISOSORBIDE MONONITRATE ER 76 69 62 64
SILVER SULFADIAZINE 75 64 63 182
ROPINIROLE HCL 71 71 64 111
CIPROFLOXACIN HCL 71 63 64 61
NEXIUM 70 59 66 43
PAROXETINE HCL 69 63 67 66
KLOR-CON M10 69 67 67 243
DIOVAN HCT 68 54 69 116
RISPERIDONE 67 67 70 49
LOSARTAN POTASSIUM 67 67 70 16
BACLOFEN 64 44 72 115
ALLOPURINOL 63 44 73 44
OXYBUTYNIN CHLORIDE ER 62 38 74 193
DIOVAN 62 60 74 48
PROMETHAZINE HCL 61 47 R 76 139
AMOX TR-POTASSIUM CLAVULANATE 60 52 77 132
LIDODERM 57 51 78 82
EXELON 56 56 79 125
ALBUTEROL SULFATE 55 42 80 69
LANTUS SOLOSTAR 52 49 81 143
TRIAMCINOLONE ACETONIDE 51 51 82 130
CEFTRIAXONE 51 44 82 285
GLIMEPIRIDE 51 47 82 38
ALENDRONATE SODIUM 50 50 85 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 12, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.